Cargando…

APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R

APOL1 risk alleles associate with chronic kidney disease in African Americans, but the mechanisms remain to be fully understood. We show that APOL1 risk alleles activate protein kinase R (PKR) in cultured cells and transgenic mice. This effect is preserved when a premature stop codon is introduced t...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Koji, Rausch, Jason W., Wakashin, Hidefumi, Fu, Yulong, Chung, Joon-Yong, Dummer, Patrick D., Shin, Myung K., Chandra, Preeti, Suzuki, Kosuke, Shrivastav, Shashi, Rosenberg, Avi Z., Hewitt, Stephen M., Ray, Patricio E., Noiri, Eisei, Le Grice, Stuart F. J., Hoek, Maarten, Han, Zhe, Winkler, Cheryl A., Kopp, Jeffrey B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220249/
https://www.ncbi.nlm.nih.gov/pubmed/30417125
http://dx.doi.org/10.1038/s42003-018-0188-2
Descripción
Sumario:APOL1 risk alleles associate with chronic kidney disease in African Americans, but the mechanisms remain to be fully understood. We show that APOL1 risk alleles activate protein kinase R (PKR) in cultured cells and transgenic mice. This effect is preserved when a premature stop codon is introduced to APOL1 risk alleles, suggesting that APOL1 RNA but not protein is required for the effect. Podocyte expression of APOL1 risk allele RNA, but not protein, in transgenic mice induces glomerular injury and proteinuria. Structural analysis of the APOL1 RNA shows that the risk variants possess secondary structure serving as a scaffold for tandem PKR binding and activation. These findings provide a mechanism by which APOL1 variants damage podocytes and suggest novel therapeutic strategies.